combination therapies outperforming semaglutide A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide vs. Semaglutide: Which is

These changes reflect growing recognition that medical weight loss including the use of GLP-1s under physician supervision is a clinically valid, life-changing treatment option

Ask your doctor to check your hormone levels." - u/Wegie_Woman The physiological truth lies somewhere between the two: rapid fat loss often causes a hormonal fluctuation - first an estrogen "wave," then a recalibration that may settle higher or lower than before

Q: Are there alternatives to Carneel Tablet

SURMOUNT-1 Eli Lilly 72 wk Additional FDA indication First and only Rx for moderate-to-severe OSA in adults with obesity

The upside potential of these drugs is exciting, but challenges linked to safety, side effects, access, and adherence need to be overcome to achieve the full impacts we anticipate